Peritoneal dialysis Microbiome and Metabolome

Incorporating monitoring of the gut microecosystem into the long-term management of PD therapy will be a new strategy, and the application of probiotics and SCFAs to improve the PD gut microbiota to reduce the risk of enterogenic peritonitis and cardiovascular events will be a new intervention.

Identifier
Source https://data.blue-cloud.org/search-details?step=~012920268BDD3E65E8D2E6F6D743E0EF1DB672A18C0
Metadata Access https://data.blue-cloud.org/api/collections/920268BDD3E65E8D2E6F6D743E0EF1DB672A18C0
Provenance
Instrument Illumina NovaSeq 6000; ILLUMINA
Publisher Blue-Cloud Data Discovery & Access service; ELIXIR-ENA
Contributor First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Publication Year 2024
OpenAccess true
Contact blue-cloud-support(at)maris.nl
Representation
Discipline Marine Science
Temporal Point 2021-01-01T00:00:00Z